Efficacy results for treatment group compared to baseline
Restless Legs Syndrome
RESTLESS LEGS SYNDROME

Primary and Key Secondary EndpointsAll treatment and control group statistics correspond to week 24 compared to the baseline of RESTFUL study entry.Abbreviations: CGI-I, Clinical Global Impressions-Improvement; IRLS, International Restless Legs Syndrome Study Group Rating Scale; MOS-I, Medical Outcomes Study Sleep Problem Index I; MOS-II, Medical Outcomes Study Sleep Problem Index II; NA, not applicable; PGI-I, Patient-Global Impressions-Improvement; SD, standard deviation.